HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

PLTEEAELELAENREILKEPVHGVY Pol(449-473) A2 human epitope
    EAELELAENREILKE Pol(453-467) human epitope
    aAELELAENREILKE Pol(453-467) observed variant
    EAgfELAENREILKE Pol(453-467) observed variant
    EAgLELAENREILKE Pol(453-467) observed variant
    EAELELAENREILeE Pol(453-467) observed variant
    EAELELAgNREILKE Pol(453-467) observed variant
        ELAENREILKEPVHGVYY Pol(457-474) C*01, C*02 human epitope
        ELAENREILKEPVHGVYY Pol(457-474) C*02:02 human epitope
        ELAENREILKEPVHGVYY Pol(457-474) human epitope
          AENREILKE Pol(459-467) human epitope
           KNREILKDPVHGVYYD Pol(460-475) human epitope
              EILKEPVGHV Pol(463-472) A*02:01 human epitope
              EILKEPVHGV Pol(463-472) A*02:01 humanized mouse epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILRIPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILqEPVHGV Pol(464-472) observed variant
               ILKEPVHGa Pol(464-472) observed variant
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human, transgenic mouse epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 transgenic mouse epitope
               ILKEPVHGV Pol(464-472) A*02:01 humanized mouse epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGa Pol(464-472) inferred escape
               ILKEPiHGa Pol(464-472) inferred escape
               ILrEPVHGV Pol(464-472) inferred escape
               ILKEPVHea Pol(464-472) inferred escape
               ILKgPVHGa Pol(464-472) inferred escape
               ILeEPVHGa Pol(464-472) inferred escape
               ILrEPVHGa Pol(464-472) inferred escape
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 humanized mouse epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 transgenic mouse epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKDPVHGV Pol(464-472) A*02:01 humanized mouse epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 transgenic mouse epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 humanized mouse epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 mouse epitope
               ILKEPVHGV Pol(464-472) A*02:01 mouse epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 transgenic mouse epitope
               ILKEPVHGV Pol(464-472) A*02:01 mouse epitope
               ILKEPVHGV Pol(464-472) A*02:01 human, macaque epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01 human epitope
               ILKEPVHGV Pol(464-472) A*02:01, A*02:05 human epitope
               ILKEPVHGV Pol(464-472) A*02:01, A2 human epitope
               ILKEPVHGV Pol(464-472) A*02:02, A2 human epitope
               ILKdPVHGV Pol(464-472) susceptible form
               ILKEPVHGV Pol(464-472) A2 transgenic mouse epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHeV Pol(464-472) susceptible form
               ILKdPVHGV Pol(464-472) non-susceptible form
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKdPVHGV Pol(464-472) diminished response
               ILKdPVHeV Pol(464-472) diminished response
               yLKEPVHGV Pol(464-472) susceptible form
               fLKEPVHGV Pol(464-472) susceptible form
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKdPVHGV Pol(464-472) observed variant
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKdPVHGV Pol(464-472) subtype-specific non-susceptible form
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKDPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human, transgenic mouse epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKDPVHGV Pol(464-472) A2 human epitope
               ILKePVHGV Pol(464-472) susceptible form
               ILRIPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKDPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 mouse epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 mouse epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 transgenic mouse epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKElVHGV Pol(464-472) escape documented in this paper
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 transgenic mouse epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGa Pol(464-472) observed variant
               IiKEPVHxx Pol(464-472) observed variant
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human, transgenic mouse epitope
               ILKdPVHGV Pol(464-472) diminished response
               ILKEPVHrV Pol(464-472) susceptible form
               ILrEPiHGV Pol(464-472) susceptible form
               ILKEPVHGi Pol(464-472) susceptible form
               ILKEPVHGV Pol(464-472) A2 transgenic mouse epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 human epitope
               ILKEPVHGV Pol(464-472) A2 supertype human, mouse epitope
               ILKEPVHGV Pol(464-472) A2 supertype human epitope
               ILKEPVHGV Pol(464-472) human epitope
               ILKEPVHGV Pol(464-472) human epitope
               ILKEPVHGV Pol(464-472) human epitope
               ILKEPVHGV Pol(464-472) human epitope
               ILKEPVHGV Pol(464-472) human epitope
               IKLEPVHGVY Pol(464-473) A*02 human epitope
               ILKEPVHGVY Pol(464-473) A*02 human epitope
               ILKEPVHGVY Pol(464-473) A2 human epitope
               ILKEPVHGVY Pol(464-473) A2 human epitope
               IKLEPVHGVY Pol(464-473) A*68:02 human epitope
               IKLEPVHGVY Pol(464-473) B*15 human epitope
               ILKEPVHGVY Pol(464-473) B*15 human epitope
               IKLEPVHGVY Pol(464-473) B*15 human epitope
               IKLEPVHGVY Pol(464-473) B*15 human epitope
               ILKEPVHGVY Pol(464-473) B15 human epitope
               ILKEPVHGVY Pol(464-473) B15 human epitope
               ILKEPVHGVY Pol(464-473) B*15:01 human epitope
               IKLEPVHGVY Pol(464-473) B*15:01 human epitope
               IKLEPVHGVY Pol(464-473) B*15:03 human epitope
               ILKEPVHGVY Pol(464-473) B*15:10 human epitope
               ILKEPVHGaY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
               ILKEtVHGaY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
               ILKEsVHGaY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
               ILKaPVHGaY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
               ILKkPVHGaY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
               ILrEPVHGaY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
               ILrEPVHGVY Pol(464-473) diminished response; escape documented in this paper; non-susceptible form
               IKLEPVHGVY Pol(464-473) B*62 human epitope
               ILKEPVHGVY Pol(464-473) B62 human epitope
               ILKEPVHGVY Pol(464-473) B62 human epitope
               IKLEPVHGVY Pol(464-473) B*81 human epitope
               ILKEPVHGVY Pol(464-473) C*03:03 human epitope
               ILrEPVHGVY Pol(464-473) escape documented in this paper
               IKLEPVHGVY Pol(464-473) C*12 human epitope
               ILKEPVHGVY Pol(464-473) C*12:02 human epitope
               ILKEPVHGaY Pol(464-473) escape documented in this paper; reversion
               ILKEPVHGVY Pol(464-473) C*12:02 human epitope
               ILKEPVHGaY Pol(464-473) altered KIR binding or increased/decreased off-rate
               ILKEPVHGVY Pol(464-473) C*12:02 human epitope
               ILKEPVHGVY Pol(464-473) human epitope
               ILKEPVHGVYY Pol(464-474) B*52:01 human epitope
               ILrEPVHGVYY Pol(464-474) diminished HLA binding or increased off-rate; observed variant
               ILKEPVHGVYY Pol(464-474) C*12:02 human epitope
               ILKEPVHGVYY Pol(464-474) C*12:02 human epitope
                LKEPVHGV Pol(465-472) human epitope
                LKEPVHGVY Pol(465-473) human epitope
                LKDPVHGVYYDPSKD Pol(465-479) human epitope
                LKDPVHGVYYDPSKD Pol(465-479) human epitope
                 KEPVHGVYY Pol(466-474) human epitope
                    VHGVYYDPSKDLIAE Pol(469-483) mouse epitope
                       VYYDPSKDL Pol(472-480) A24 human epitope
                       VYYDPSKDL Pol(472-480) A*36 human epitope
                       VYYDPSKDLI Pol(472-481) H-2Kd mouse epitope
                       VYYDPSKDLv Pol(472-481) susceptible form
                       VYYDPtKDLI Pol(472-481) susceptible form
                       VYYDPSKeLI Pol(472-481) diminished response; non-susceptible form
                       aYYDPSKeLI Pol(472-481) diminished response; non-susceptible form
                       VYYePSKeLI Pol(472-481) diminished response; non-susceptible form
                       VYYDPSKDIA Pol(472-481) H-2Kd mouse epitope
                       VYYDPSKDLI Pol(472-481) H-2d human, mouse epitope
                       VYYDPSKDLIA Pol(472-482) H-2Kd mouse epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health